ReviewAntibodies (Basel, Switzerland)2023

CCR6 as a Potential Target for Therapeutic Antibodies for the Treatment of Inflammatory Diseases.

Sara Gómez-Melero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.